MEI Pharma Inc. (Nasdaq: MEIP) has successfully closed a $100 million private placement for the purchase and sale of 29,239,767 shares of common stock at a price of $3.42 per share. This transaction supports MEI's initiative to implement a Litecoin Treasury Strategy, making it the first publicly traded company to adopt Litecoin as a primary treasury reserve asset. As part of this strategic move, MEI has appointed Charlie Lee, the creator of Litecoin, to its Board of Directors and has engaged GSR as its digital asset and treasury management advisor. The funds will be used to acquire Litecoin, enhancing MEI's cash management framework with a decentralized monetary asset. Titan Partners Group served as the sole placement agent for this transaction.